Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 647

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 647
---
lected within Pro Forma Adjustment A in Note 4 of the notes to the unaudited pro forma condensed combined financial information).

431

The Concurrent Investment

In connection with the Merger Agreement and as a condition precedent to the completion of the Mergers, the Company plans to enter into
subscription agreements with interested investors to purchase TuHURA Common Stock for gross proceeds of at least $20,000,000. TuHURA has not currently executed any subscription agreement in connection with the contemplated Concurrent Investment. The
Concurrent Investment is presented in the unaudited pro forma condensed combined financial statement as contemplated since it is a condition of closing of the Mergers. The Concurrent Investment is currently estimated for purposes of these pro formas
to be the issuance of 4,952,579 shares of TuHURA Common Stock at a purchase price of approximately $4.0383 per share (based on the 10-day Volume-weighted average price, or “VWAP”, of the TuHURA share
price as of April 30, 2025, which will be adjusted based on the 10-day VWAP as of the date that each investor subscribes to the Concurrent Investment) with net proceeds of $18,400,000 after $1,600,000 of
estimated equity issuance costs (the Concurrent Investment is reflected within Pro Forma Adjustment C in Note 4 of the notes to the unaudited pro forma condensed combined financial information).

432

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF DECEMBER 31, 2024

| ASSETS                                         
 Current assets:                                |     | TuHURA            
 Biosciences, Inc. |            |     | Kineta       
 (Historical) |            |     | Additional 
 Financings |            |   |     |   |     | Pro Forma   
 Adjustments |            |   |     |    |     | Pro Forma 
 Combined  |            |
|:-----------------------------------------------|:----|:------------------|-----------:|:----|:-------------|-----------:|:----|:-----------|-----------:|:--|:----|:--|:----|:------------|-----------:|:--|:----|:---|:----|:----------|-----------:|
| Cash and cash equivalents                      |     | $                 | 12,657,178 |     | $            |    633,501 |     | $